| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 | ||||
| 合计 | 575,832,300.00 | 377,407,800.00 | -- | 34.45 | ||||
| 减：抵销 | 82,659,200.00 | 81,906,900.00 | 752,300.00 | 0.91 | ||||
| 抗感染药 | 70,767,900.00 | 75,884,000.00 | -5,116,100.00 | -- | ||||
| 抗寄生虫药 | 138,124,600.00 | 105,221,500.00 | 32,903,100.00 | 23.82 | ||||
| 抗寄生虫药C8 医药、生物药品 C85 生物药品业 | 138,124,600.00 | 105,221,500.00 | 32,903,100.00 | 23.82 | ||||
| 抗肿瘤药 | 235,480,900.00 | 83,635,700.00 | 151,845,200.00 | 64.48 | ||||
| 其他 | 133,530,600.00 | 127,242,200.00 | 6,288,400.00 | 4.70 | ||||
| 心血管药 | 80,587,200.00 | 67,331,200.00 | 13,256,000.00 | 16.44 | ||||
9/9 转到 
